Jindrich Cinatl

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 10

Top Topics

Respiratory Syndrome Coronavirus

Acute Myeloid Leukemia

Top Venues

Nature medicine

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Denisa Bojkova, Marek Widera, Sandra Ciesek, Mark N Wass, Martin Michaelis, Jindrich Cinatl
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates. Cell research 32 (3) (2022)
Rebekka Karlowitz, Megan L Stanifer, Jens Roedig, Geoffroy Andrieux, Denisa Bojkova, Marco Bechtel, Sonja Smith, Lisa Kowald, Ralf Schubert, Melanie Boerries, Jindrich Cinatl, Steeve Boulant, Sjoerd J L van Wijk
USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING. Cell death & disease 13 (8) (2022)
Denisa Bojkova, Tamara Rothenburger, Sandra Ciesek, Mark N Wass, Martin Michaelis, Jindrich Cinatl
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment. Cell discovery 8 (1) (2022)
Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Oliver Keminer, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection. Scientific data 8 (1) (2021)
Jane Louise Ward, Yanqi Wu, Claudia Harflett, Hannah Onafuye, Delia Corol, Charlotte Lomax, William J Macalpine, Jindrich Cinatl, Mark N Wass, Martin Michaelis, Michael H Beale
Miyabeacin: A new cyclodimer presents a potential role for willow in cancer therapy. Scientific reports 10 (1) (2020)
Donghyuk Shin, Rukmini Mukherjee, Diana Grewe, Denisa Bojkova, Kheewoong Baek, Anshu Bhattacharya, Laura Schulz, Marek Widera, Ahmad Reza Mehdipour, Georg Tascher, Paul P Geurink, Alexander Wilhelm, Gerbrand J van der Heden van Noort, Huib Ovaa, Stefan Müller, Klaus-Peter Knobeloch, Krishnaraj Rajalingam, Brenda A Schulman, Jindrich Cinatl, Gerhard Hummer, Sandra Ciesek, Ivan Đikić
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587 (7835) (2020)
Denisa Bojkova, Kevin Klann, Benjamin Florian Koch, Marek Widera, David Krause, Sandra Ciesek, Jindrich Cinatl, Christian Münch
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583 (7816) (2020)
Tamara Rothenburger, Katie-May McLaughlin, Tobias Herold, Constanze Schneider, Thomas Oellerich, Florian Rothweiler, Andrew Feber, Tim R Fenton, Mark N Wass, Oliver T Keppler, Martin Michaelis, Jindrich Cinatl
SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine. Communications biology 3 (1) (2020)
Thomas Oellerich, Constanze Schneider, Dominique Thomas, Kirsten M Knecht, Olga Buzovetsky, Lars Kaderali, Christoph Schliemann, Hanibal Bohnenberger, Linus Angenendt, Wolfgang Hartmann, Eva Wardelmann, Tamara Rothenburger, Sebastian Mohr, Sebastian Scheich, Federico Comoglio, Anne Wilke, Philipp Ströbel, Hubert Serve, Martin Michaelis, Nerea Ferreirós, Gerd Geisslinger, Yong Xiong, Oliver T Keppler, Jindrich Cinatl
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML. Nature communications 10 (1) (2019)
Constanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, Sarah-Marie Schwarz, Dominique Thomas, Robert Flick, Hanibal Bohnenberger, Lars Kaderali, Lena Stegmann, Anjali Cremer, Margarethe Martin, Julian Lohmeyer, Martin Michaelis, Veit Hornung, Christoph Schliemann, Wolfgang E Berdel, Wolfgang Hartmann, Eva Wardelmann, Federico Comoglio, Martin-Leo Hansmann, Alexander F Yakunin, Gerd Geisslinger, Philipp Ströbel, Nerea Ferreirós, Hubert Serve, Oliver T Keppler, Jindrich Cinatl
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nature medicine 23 (2) (2016)